About
Sight Sciences, Inc. is a medical technology company founded in 2011 by brothers Paul and David Badawi. Headquartered in Menlo Park, California, the company focuses on developing innovative ophthalmic technologies to address significant needs in eye care, particularly for chronic conditions like glaucoma and ocular surface disease. The company offers two main product lines: the OMNI Surgical System, a minimally invasive device for treating open-angle glaucoma, and the TearCare System, which addresses dry eye disease by targeting meibomian gland dysfunction. Both products are clinically validated and designed to improve patient outcomes in eyecare practices. Sight Sciences serves ophthalmologists and optometrists, aiming to enhance treatment options for millions of patients worldwide. Incorporated in 2011, Sight Sciences went public on Nasdaq in 2021 and reported revenues of $71.6 million in 2023. The company emphasizes a science-first approach and collaborates with the eyecare community to improve vision health globally.
Technologies
Keywords
Company Information
-
Employees 220
-
Founded 2011
-
Annual Revenue $79866000
-
Total Funding $389939969
Location
4040 Campbell Ave, Menlo Park, California, United States, 94025